Specifically, people with a personal or family history of thyroid cancer, including medullary thyroid carcinoma (MTC), should not use semaglutide GLP-1 due to an increased risk of developing thyroid tumors
This gradual shift prevents a large spike in medication levels
How Do Semaglutides and Tirzepatides Work
Adoption remained modest until recent years as GLP-1 drug claims rose from 6.9 percent in 2023 to 10.5 percent in 2025
This has led many patients and healthcare professionals to consider protein supplementation , with whey protein being one of the most popular and well-researched options available
While meeting the BMI threshold (e.g., 30+, or 27+ with a comorbidity) is a necessary first step, it does not guarantee approval